Home

Solution

Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma

2025-12-24

By admin

Cutting-edge research in liver cancer diagnosis highlights Celnovte antibodies!
A recent publication in World Journal of Gastrointestinal Oncology (May 2025) by Guangxi Medical University explored novel diagnostic biomarkers for hepatocellular carcinoma (HCC) — integrating serum, bile, and fecal markers to improve early detection.
The study demonstrated that combining bile AFP and serum PIVKA-II achieved an AUC of 0.965, markedly enhancing diagnostic accuracy, especially for early-stage HCC. Read more：https://pmc.ncbi.nlm.nih.gov/articles/PMC12142260/
We’re proud that Celnovte’s polymerized HRP-conjugated secondary antibody (SD3003) played a key role in the immunohistochemical analysis of AFP expression, ensuring high sensitivity and reproducibility in detecting tumor markers.
🔬 Reliable tools empower impactful science.
👉 Explore more about our antibody solutions for tumor pathology and translational research: [https://lnkd.in/gkD38EXV]